pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    RGDCRAdcox-2F
    Pancreatic Cancer University of Minnesota
  • Preclinical
    RGN-6024
    Glioblastoma Multiforme (GBM) Reglagene Holding Inc
  • Phase 1
    RGT-61159
    Adenoid Cystic Carcinoma (ACC) Rgenta Therapeutics Inc
  • Phase 1
← prev
page 32 of 62
next →
Pain89
Neurology1
RGVax
Human Papillomavirus (HPV) Associated Cancer
Pathovax LLC
  • Preclinical
    RK-33
    Triple-Negative Breast Cancer (TNBC) Natsar Pharmaceuticals Inc
  • Phase 2
    RNK-05047
    Diffuse Large B-Cell Lymphoma Ranok Therapeutics Co Ltd
  • Phase 1
    ROSE-12
    Solid Tumor Chugai Pharmaceutical Co Ltd
  • Preclinical
    RP-001
    Breast Cancer Recurv Pharma Inc
  • Phase 2
    RP-323
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) PhorMed Inc
  • Preclinical
    RS-5
    Soft Tissue Sarcoma Resolute Science Inc
  • Phase 2
    RV-01
    Castration-Resistant Prostate Cancer (CRPC) Radiopharm Ventures LLC
  • Phase 2
    RX-0301
    Hepatocellular Carcinoma Zhejiang Haichang Biotechnology Co Ltd
  • Phase 2
    RZ-001
    Glioblastoma Multiforme (GBM) Rznomics Inc
  • Phase 2
    Radspherin
    Colorectal Cancer Oncoinvent ASA
  • Marketed
    Regenecyte
    Regenecyte
    Blood Cancer StemCyte Inc
  • Marketed
    Rylaze
    Rylaze (asparaginase erwinia chrysanthemi-rywn)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$JAZZ Jazz Pharmaceuticals plc
  • Phase 2
    S-531011
    Adenocarcinoma Of The Gastroesophageal Junction$SGIOF SHIONOGI & CO LTD
  • Phase 2
    SA-53
    Dedifferentiated Liposarcoma Lamassu Bio Inc
  • Phase 1
    SACT-1
    Neuroblastoma$APM Aptorum Group Ltd
  • Phase 2
    SAF-189
    Non-Small Cell Lung Cancer Fochon Pharmaceutical Ltd
  • Phase 1
    SAR-446523
    Refractory Multiple Myeloma$SNY Sanofi
  • Preclinical
    SAR-BBN
    Metastatic Breast Cancer Clarity Pharmaceuticals Ltd
  • Phase 2
    SB-11285
    Cervical Cancer invoX Pharma Ltd
  • Phase 1
    SBE-303
    Solid Tumor Samsung Bioepis Co Ltd
  • Preclinical
    SBI-1301
    Prostate Cancer Soricimed Biopharma Inc
  • Phase 1
    SBO-154
    Breast Cancer Sun Pharma Advanced Research Company Ltd
  • Preclinical
    SBT-100
    Osteosarcoma Singh Biotechnology LLC
  • Preclinical
    SC-134
    Small-Cell Lung Cancer Scancell Holdings Plc
  • Phase 1
    SCDARIC-33
    Refractory Acute Myeloid Leukemia$REGN REGENERON PHARMACEUTICALS, INC.
  • Phase 2
    SCG-101
    Hepatocellular Carcinoma SCG Cell Therapy Pte Ltd